Does Dr. PAUL ARNSTEIN have financial conflicts of interest?

Dr. PAUL ARNSTEIN (ARNP) has received a total of $1,710 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $1,710 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. PAUL ARNSTEIN?

According to CMS Open Payments data, Dr. PAUL ARNSTEIN received funding from VERTEX PHARMACEUTICALS INCORPORATED ($990) and KOWA PHARMACEUTICALS AMERICA ($720).

Does Dr. PAUL ARNSTEIN receive research grants or speaking fees?

Dr. PAUL ARNSTEIN has received $1,710 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. PAUL ARNSTEIN

ARNPReal-Time Hydrated

Specialty: Nurse Practitioner

Practice Location: MANCHESTER, NH 03103

NPI Number: 1184686131

LIFETIME INDUSTRY VALUE

$1,710

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. ARNSTEIN is a verified Nurse Practitioner practitioner based in MANCHESTER, NH.

Between 2021 and 2025, Dr. ARNSTEIN had an overall industry promotional and research financial footprint of $1,710 as recorded in the federal CMS Open Payments database.

$1,710 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ARNSTEIN's primary funding source is VERTEX PHARMACEUTICALS INCORPORATED, which accounts for $990 (representing 57.9% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

VERTEX PHARMACEUTICALS INCORPORATED

Rank 1

$990

57.9%

KOWA PHARMACEUTICALS AMERICA

Rank 2

$720

42.1%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.